Table 1 Patients’ clinicopathological characteristics
Characteristics | N = 100 |
|---|---|
Agea | 68,49 (62–78) |
Gender | |
M | 64 (64%) |
F | 36 (36%) |
Tumor location | |
Upper | 10 (10%) |
Body | 38 (38%) |
Lower | 47 (47%) |
Linitis | 5 (5%) |
Gastrectomy | |
Total | 42 (42%) |
Subtotal | 58 (58%) |
Lymphadenectomy | |
D1 | 36 (36%) |
D2 | 46 (46%) |
+ | 18 (18%) |
HIPEC | |
Yes | 11 (11%) |
No | 89 (89%) |
Adjuvant chemotherapyb | |
Yes | 42 (42%) |
No | 35 (35%) |
Surgical radicalityb | |
0 | 38 (38%) |
1 | 18 (18%) |
2 | 43 (43%) |
pT | |
1 | 0 |
2 | 2 (2%) |
3 | 32 (32%) |
4a | 54 (54%) |
4b | 12 (12%) |
pN | |
0 | 2 (2%) |
1 | 7 (7%) |
2 | 14 (14%) |
3 | 71 (71%) |
x | 6 (6%) |
Lymph nodes harvestedb | 40.85 (28–53) |
Peritoneal involvementb | |
P1 | 34 (34%) |
P2 | 17 (17%) |
P3 | 23 (23%) |
Lauren’s typeb | |
Intestinal | 37 (37%) |
Diffuse | 46 (46%) |
Mixed | 16 (16%) |